Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation

To examine radio frequency ablation as a treatment supplement to stimulate immunogenicity and improve survival for patients undergoing curative-intent surgery for colorectal liver metastases.

Trial Details

NCT ID
NCT04798898
Phase
NA
Sponsor
University of Aarhus
Status
RECRUITING
Cancer Type
Liver Cancer
Interventions
  • RFA (radiofrequency ablation)
Locations (sample)
  • Aarhus, Denmark|56.15674,10.21076

Key Eligibility Criteria

  • Patients with colorectal liver metastases planned for resection
  • At least one tumor size \>=3cm
  • Performance status 0-1

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Liver Cancer Trials on Trialify →